ROTHSCHILD INVESTMENT LLC /IL - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROTHSCHILD INVESTMENT LLC /IL ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,230
-23.8%
40,084
-0.6%
0.10%
-22.4%
Q2 2023$1,615
+326.1%
40,327
+333.9%
0.13%
+306.1%
Q1 2023$379
+5.6%
9,2940.0%0.03%0.0%
Q4 2022$359
-99.9%
9,294
+0.7%
0.03%
-32.7%
Q3 2022$491,000
-8.9%
9,2310.0%0.05%
-2.0%
Q2 2022$539,000
-22.1%
9,231
+1.9%
0.05%
-7.4%
Q1 2022$692,000
+28.9%
9,057
+1.5%
0.05%
+28.6%
Q4 2021$537,000
+7.4%
8,9230.0%0.04%0.0%
Q3 2021$500,000
-7.7%
8,923
-0.1%
0.04%
-2.3%
Q2 2021$542,000
-15.7%
8,933
-2.7%
0.04%
-21.8%
Q1 2021$643,000
+31.2%
9,181
+12.1%
0.06%
+17.0%
Q4 2020$490,000
-9.4%
8,190
-9.0%
0.05%
-20.3%
Q3 2020$541,000
+27.9%
8,998
+11.7%
0.06%
+15.7%
Q2 2020$423,000
-51.2%
8,059
-68.8%
0.05%
-54.9%
Q1 2020$866,000
+189.6%
25,813
+290.6%
0.11%
+276.7%
Q4 2019$299,0006,6090.03%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Tamarack Advisers, LP 360,000$21,845,0006.19%
Gagnon Advisors, LLC 213,217$12,938,0004.92%
GAGNON SECURITIES LLC 499,333$30,300,0004.30%
Spyglass Capital Management LLC 2,117,673$128,500,0002.86%
NEUMEIER POMA INVESTMENT COUNSEL LLC 646,530$39,231,0002.30%
Paulson & Co. 1,273,161$77,255,0001.85%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 212,112$12,871,0001.44%
Tygh Capital Management, Inc. 152,332$9,244,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,147,000$69,600,0001.24%
Rock Springs Capital Management LP 1,025,000$62,197,0001.23%
View complete list of PACIRA PHARMACEUTICALS INC shareholders